Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC, commonly known as MSD, is a leading global healthcare company headquartered in the United States. Founded in 1891, MSD has established a strong presence in various operational regions, including Europe, Asia, and Latin America, focusing on innovative pharmaceuticals, vaccines, and animal health products. With a commitment to research and development, MSD is renowned for its core offerings, which include groundbreaking treatments in oncology, infectious diseases, and vaccines. The company has achieved significant milestones, such as the development of key therapies that have transformed patient care. Recognised for its robust market position, MSD continues to be a pioneer in the pharmaceutical industry, driven by a mission to improve health outcomes worldwide.
DitchCarbon Score
How does Merck Sharp & Dohme LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Merck Sharp & Dohme LLC's score of 47 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Merck Sharp & Dohme LLC's reported carbon emissions
In 2018, Merck Sharp & Dohme LLC reported carbon emissions of approximately 245.3 kg CO2e, specifically from Scope 2, which pertains to purchased electricity. The company has set ambitious climate commitments, aiming to reduce its greenhouse gas emissions by at least 40% from 2015 levels by the year 2025. This target applies to both Scope 1 and market-based Scope 2 emissions, in alignment with the GHG Protocol. These initiatives reflect Merck Sharp & Dohme's commitment to addressing climate change and reducing its carbon footprint in the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | |
|---|---|
| Scope 1 | - |
| Scope 2 | 245.3 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Merck Sharp & Dohme LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
